Indiana Federal Judge Dismisses Teva’s Lawsuit Against Eli Lilly Over Osteoporosis Drug Patent Agreement

An Indiana federal judge has dismissed a lawsuit filed by Teva Pharmaceuticals USA Inc. against Eli Lilly and Co. concerning a patent agreement related to Forteo, a drug used in the treatment of osteoporosis. Teva alleged that Eli Lilly breached their settlement agreement, but the judge concluded that Eli Lilly’s obligation to waive exclusivity ceased when the drug’s patents expired. For further legal analysis and commentary on this case, see Law360’s detailed report.